These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11407351)

  • 21. Glycogen storage diseases and cardiomyopathy.
    Roos JC; Cox TM
    N Engl J Med; 2005 Jun; 352(24):2553; author reply 2553. PubMed ID: 15958815
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac manifestations of PRKAG2 mutation.
    Banankhah P; Fishbein GA; Dota A; Ardehali R
    BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.
    MacRae CA; Ghaisas N; Kass S; Donnelly S; Basson CT; Watkins HC; Anan R; Thierfelder LH; McGarry K; Rowland E
    J Clin Invest; 1995 Sep; 96(3):1216-20. PubMed ID: 7657794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of the MYH7 gene in a child with hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome.
    Bobkowski W; Sobieszczańska M; Turska-Kmieć A; Nowak A; Jagielski J; Gonerska M; Lebioda A; Siwińska A
    J Appl Genet; 2007; 48(2):185-8. PubMed ID: 17495353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial hypertrophic cardiomyopathy and preexcitation.
    Hauser AM; Gordon S; Timmis GC
    Am Heart J; 1984 Jan; 107(1):176-9. PubMed ID: 6229172
    [No Abstract]   [Full Text] [Related]  

  • 27. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.
    Laforêt P; Richard P; Said MA; Romero NB; Lacene E; Leroy JP; Baussan C; Hogrel JY; Lavergne T; Wahbi K; Hainque B; Duboc D
    Neuromuscul Disord; 2006 Mar; 16(3):178-82. PubMed ID: 16487706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating phenotypic expression of the PRKAG2 cardiac syndrome.
    Gollob MH
    Circulation; 2008 Jan; 117(2):134-5. PubMed ID: 18195183
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical Spectrum of PRKAG2 Syndrome.
    Porto AG; Brun F; Severini GM; Losurdo P; Fabris E; Taylor MRG; Mestroni L; Sinagra G
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003121. PubMed ID: 26729852
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial Wolff-Parkinson-White syndrome is linked to the loci on chromosome 7q3.
    Liu W; Liu G; Hu D; Qi Y; Shan Z; Yang D; Liu D; Wang Y
    Chin Med J (Engl); 2002 Nov; 115(11):1733-5. PubMed ID: 12609097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A contemporary approach to hypertrophic cardiomyopathy.
    Ho CY; Seidman CE
    Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342
    [No Abstract]   [Full Text] [Related]  

  • 32. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy.
    Wang SB; Weng WC; Lee NC; Hwu WL; Fan PC; Lee WT
    Pediatr Neonatol; 2008 Aug; 49(4):145-9. PubMed ID: 19054921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial forms of hypertrophic cardiomyopathy].
    Popov VG; Sedov VP
    Ter Arkh; 1986; 58(11):68-70. PubMed ID: 3824193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy.
    Mogensen J; Bahl A; Kubo T; Elanko N; Taylor R; McKenna WJ
    J Med Genet; 2003 May; 40(5):e59. PubMed ID: 12746413
    [No Abstract]   [Full Text] [Related]  

  • 35. AMP-activated protein kinase conducts the ischemic stress response orchestra.
    Young LH
    Circulation; 2008 Feb; 117(6):832-40. PubMed ID: 18268160
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
    Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S
    Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A familial form of conduction defects associated with a PRKAG2 gene mutation].
    Pochmalicki G; Genest M; Richard P; Komajda M; Charron P
    Arch Mal Coeur Vaiss; 2007 Sep; 100(9):760-5. PubMed ID: 18033003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare forms of preexcitation: a case study and brief overview of familial forms of preexcitation.
    Koneru JN; Wood MA; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):e82-7. PubMed ID: 22895604
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetically transmitted ventricular pre-excitation in a family with hypertrophic cardiomyopathy.
    Sinha SC; Nair M; Gambhir DS; Mohan JC; Kaul UA; Arora R
    Indian Heart J; 2000; 52(1):76-8. PubMed ID: 10820940
    [No Abstract]   [Full Text] [Related]  

  • 40. AMP-activated protein kinase: a key stress signaling pathway in the heart.
    Young LH; Li J; Baron SJ; Russell RR
    Trends Cardiovasc Med; 2005 Apr; 15(3):110-8. PubMed ID: 16039971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.